
DENMARK - Nordic Phytopharma A/S is sold to Scandinavian Clinical Nutrition AB
Scandinavian Clinical Nutrition AB (SCN) has acquired Nordic Phytopharma, a Danish pharmaceutical business and Biolink Capital portfolio company, for SEK 60m including an earn-out. SCN will pay for the pharmaceutical in cash and shares. The acquisition gives Scandinavian Clinical Nutrition access to two patented products within immune system boosting and the treatment of the common cold. The acquisition will also strengthen SCN's export activities to Europe, Asia and South America
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater